Volume 30, Number 1—January 2024
Research
Effectiveness of Vaccines and Antiviral Drugs in Preventing Severe and Fatal COVID-19, Hong Kong
Figure 4

Figure 4. Cumulative hazards for serious/critical/fatal condition outcome events in study of effectiveness of vaccines and antiviral drugs in preventing severe and fatal COVID-19, Hong Kong. Cumulative hazards were compared among age groups, patients prescribed oral antiviral drugs, and those unvaccinated or vaccinated with CoronaVac or Comirnaty vaccines. A) No antiviral drugs, B) molnupiravir, C) nirmatrelvir/ritonavir. Antiviral drugs were prescribed within 5 days after confirmation of a COVID-19 diagnosis. Colors indicate age groups within each treatment group.
1These first authors contributed equally to this manuscript.